American firms have begun releasing large numbers of insects into the environment as a biological method to curb the Asian tiger mosquito, a known carrier of several viral illnesses. On August 7, 2026, the companies deployed hundreds of thousands of mosquitoes across selected sites in the United States, aiming to lower the population of disease‑spreading tiger mosquitoes.
Étienne Normandin of the Institut de recherche en biologie végétale at the University of Montreal explained that the approach relies on releasing sterile or otherwise modified mosquitoes that compete with wild tiger mosquitoes for mates, thereby reducing the overall number of vectors capable of transmitting dengue, chikungunya and Zika viruses. The strategy represents a shift from traditional chemical insecticides toward a biological control technique that targets the pest’s reproductive cycle.
The testing phase is being conducted by the unnamed U.S. companies as part of a broader effort to assess the effectiveness and safety of mass mosquito releases. Researchers are monitoring the impact on local tiger mosquito populations and tracking any changes in disease transmission risk. If successful, the method could become a scalable tool for public‑health agencies seeking to manage mosquito‑borne diseases without relying heavily on pesticides. The initiative reflects growing interest in environmentally based solutions to protect communities from the health threats posed by the invasive Asian tiger mosquito.